UnitedHealth Group Incorporated
CorpDigest
UnitedHealth Group Incorporated
Financial Performance
Last reviewed: June 2026 · By Swet Parvadiya
Revenue
$400.3B
Market Cap
$290.0B
Net Income
$16.4B
Employees
440,000
UnitedHealth Group earned $16.4 billion in net income on $400.3 billion in fiscal 2024 revenue — a 4.1% net margin that reflects the thin economics of health insurance (where medical loss ratios above 80% are standard) combined with the higher-margin services businesses within Optum. The $400.3 billion revenue figure represents growth from $287.6 billion in fiscal 2021, $324.2 billion in fiscal 2022, and $371.6 billion in fiscal 2023 — consistent double-digit growth that has continued through every economic cycle. The Change Healthcare attack cost more than $3.1 billion in fiscal 2024 — an extraordinary single-event expense that reduced net income meaningfully below what normalized operations would have generated. Remediation costs, advance payments to providers waiting on claims processing, and disruption expenses combined to create a financial impact larger than the annual revenues of most healthcare companies. The $290 billion market capitalization prices UnitedHealth at approximately 0.73 times fiscal 2024 revenue — a low multiple given the growth trajectory, but one that reflects both the thin insurance margins and the regulatory risk embedded in the company's vertical integration. If Optum's services businesses were separately valued at software and healthcare services multiples, and UnitedHealthcare's insurance business at insurance multiples, the sum of parts calculation would likely exceed the current consolidated market cap. The 440,000 employees generate $400.3 billion in revenue — roughly $909,000 per employee, a productivity figure that reflects the insurance business model's ability to process enormous premium volumes without proportional headcount requirements. The Optum physician workforce is embedded in that total, but the actuarial and claims processing infrastructure that manages most of the medical expenditure requires far fewer workers per dollar of premium than the care delivery operations.
Revenue Trend Analysis
YoY Change
+7.7%
4-Year CAGR
+11.7%
Peak Year
2024
Trend
Consistent Growth
UnitedHealth Group Incorporated has reported revenue across 5 fiscal years, compounding at +11.7% annually over 4 years. The most recent year saw a 7.7% increase versus the prior year. Revenue peaked in 2024 at $400.3B. Out of 4 reported periods, 4 showed growth and 0 showed a decline.
| Fiscal Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2024 | $400.3B | $16.4B | +7.7% |
| FY2023 | $371.6B | — | +14.6% |
| FY2022 | $324.2B | — | +12.7% |
| FY2021 | $287.6B | — | +11.8% |
| FY2020 | $257.1B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.
Click any row to see year details.
UnitedHealth Group reported $400.28 billion in 2024 revenue, up roughly 8 percent from $371.6 billion in 2023, making it the largest healthcare company globally by top line and the fourth-largest US company of any kind. Operating earnings reached $32.3 billion despite a $2.45 billion charge tied to the Change Healthcare cyberattack and roughly $7 billion in business disruption impacts disclosed across the year. Net earnings attributable to shareholders came in at $14.4 billion, compressed by the cyberattack costs, a $7.1 billion noncash charge on the South America divestiture in Brazil, and rising Medicare Advantage utilization. Adjusted earnings per share were $27.66 versus reported diluted EPS of $15.51. The board returned roughly $16 billion to shareholders through dividends and buybacks. The medical care ratio finished at 85.5 percent. Cash flows from operations totaled about $24.2 billion, and the company ended the year with roughly $29 billion of long-term debt and an A-rated credit profile, though the rating outlook was revised to negative by Moody's in 2025.
UnitedHealth Group disclosed that the February 2024 ransomware attack on Change Healthcare cost the company $2.45 billion in 2024, including approximately $1.4 billion in direct response and remediation costs and the balance in business disruption impacts. Direct costs covered the reported $22 million ransom payment, forensic investigation, customer notification for roughly 190 million affected Americans, identity protection services, and rebuilding the clearinghouse and pharmacy network technology platforms. Business disruption included unbilled revenue while the platform was offline and elevated medical costs at UnitedHealthcare. Separately, the company advanced more than $9 billion in interest-free loans to providers awaiting claim payments, with most repaid by year end. The cyberattack contributed to a roughly $1 billion reduction in 2024 adjusted operating earnings versus management's pre-incident outlook, and the company has continued to record incremental costs into 2025 as litigation, class actions from the breach, and federal Office for Civil Rights review proceed.
UnitedHealth Group is one of the largest capital returners in the S&P 500, distributing approximately $16 billion to shareholders in 2024 through a combination of dividends and share repurchases. The quarterly dividend has been raised every year since the company initiated a regular payout in 2010, growing from $0.50 annually to $8.40 per share in 2024 after a roughly 12 percent increase announced in June. The dividend payout ratio sits near 30 percent of adjusted earnings, leaving room for further increases. Buybacks reduced the share count from roughly 1.05 billion in 2010 to about 920 million by year-end 2024. The company maintained a target capital structure with debt to total capital near 40 percent and consistently held A-range credit ratings, supporting access to bond markets where it issued investment-grade paper to fund deals like Change Healthcare. Total shareholder return over the decade ended 2024 exceeded 400 percent, though 2024 itself saw the stock decline as cyberattack and political pressure weighed.
UnitedHealth Group's market capitalization, which had topped $550 billion in late 2024, fell sharply through the first half of 2025 to roughly $290 billion as a combination of operational and policy pressures hit results. In April the company missed first-quarter earnings expectations because Medicare Advantage utilization came in materially higher than priced, with seniors increasing physician visits and elective procedures. In May, Andrew Witty stepped down and the company withdrew its full-year 2025 guidance citing volatile medical costs. The Justice Department reportedly opened a criminal investigation into Medicare Advantage billing practices, and a separate civil antitrust probe of Optum continued. The medical care ratio reached 89.4 percent in the second quarter, well above the 86 to 87 percent range investors had expected. Stephen Hemsley returned as CEO and signaled a 2026 reset focused on pricing discipline, exiting unprofitable Medicare Advantage counties, and limiting further large acquisitions until regulatory uncertainty resolves.
Using these figures? Please credit CorpDigest with a link.
CorpDigest. "UnitedHealth Group Incorporated Revenue & Financials." CorpDigest, https://corpdigest.com/company/unitedhealth/financials.<div style="font-family:system-ui,sans-serif;font-size:14px;line-height:1.5;border:1px solid #e2e8f0;border-radius:8px;padding:12px 16px;max-width:520px"><strong>UnitedHealth Group Incorporated reported $400B in revenue (FY2024).</strong><br>Source: <a href="https://corpdigest.com/company/unitedhealth/financials" target="_blank" rel="noopener">CorpDigest — UnitedHealth Group Incorporated financials</a></div>